Effect of spermidine on misfolding and interactions of Alpha-synuclein

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Krasnoslobodtsev, Alexey V ^a   Peng, Jie ^a,b   Asiago, Josephat M ^c   Hindupur, Jagadish ^c   Rochet, Jean Christophe ^c   Lyubchenko, Yuri L ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; PROTEIN A30P; PROTEIN VARIANT; SPERMIDINE; UNCLASSIFIED DRUG;

ARTICLE; ATOMIC FORCE MICROSCOPY; CARBOXY TERMINAL SEQUENCE; DIMERIZATION; FORCE SPECTROSCOPY; MOLECULAR INTERACTION; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN ASSEMBLY; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN IMMOBILIZATION; PROTEIN INTERACTION; SPECTROSCOPY; WILD TYPE;

ALPHA-SYNUCLEIN; HUMANS; MICROSCOPY, ATOMIC FORCE; PROTEIN FOLDING; PROTEIN MULTIMERIZATION; SPERMIDINE;

EID: 84861471138     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0038099     Document Type: Article

References (49)

1. Tong J, Wong H, Guttman M, Ang LC, Forno LS, et al. (2010) Brain α-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation. Brain 133: 172-188.
2. Weinreb PH, Zhen W, Poon AW, Conway KA, Lansbury PT, (1996) NACP, A Protein Implicated in Alzheimer's Disease and Learning, Is Natively Unfolded†. Biochemistry 35: 13709-13715.
3. Bisaglia M, Mammi S, Bubacco L, (2009) Structural insights on physiological functions and pathological effects of alpha-synuclein. The FASEB journal: official publication of the Federation of American Societies for Experimental Biology 23: 329-340.
4. Eliezer D, Kutluay E, Bussell R Jr, Browne G, (2001) Conformational properties of alpha-synuclein in its free and lipid-associated states. Journal of molecular biology 307: 1061-1073.
5. Kruger R, Kuhn W, Muller T, Woitalla D, Graeber M, et al. (1998) Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat Genet 18: 106-108.
6. Zarranz JJ, Alegre J, Gómez-Esteban JC, Lezcano E, Ros R, et al. (2004) The new mutation, E46K, of α-synuclein causes parkinson and Lewy body dementia. Annals of Neurology 55: 164-173.
7. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, et al. (1997) Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease. Science 276: 2045-2047.
8. Narhi L, Wood SJ, Steavenson S, Jiang Y, Wu GM, et al. (1999) Both familial Parkinson's disease mutations accelerate alpha-synuclein aggregation. The Journal of biological chemistry 274: 9843-9846.
9. Chen L, Feany MB, (2005) α-Synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease. Nat Neurosci 8: 657-663.
10. Conway KA, Rochet JC, Bieganski RM, Lansbury PT Jr, (2001) Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct. Science 294: 1346-1349.
11. Serpell LC, Berriman J, Jakes R, Goedert M, Crowther RA, (2000) Fiber diffraction of synthetic α-synuclein filaments shows amyloid-like cross-β conformation. Proceedings of the National Academy of Sciences 97: 4897-4902.
12. Beyer K, (2006) α-Synuclein structure, posttranslational modification and alternative splicing as aggregation enhancers. Acta Neuropathologica 112: 237-251.
13. Hashimoto M, Hsu LJ, Sisk A, Xia Y, Takeda A, et al. (1998) Human recombinant NACP/α-synuclein is aggregated and fibrillated in vitro: Relevance for Lewy body disease. Brain Research 799: 301-306.
14. Uversky VN, Li J, Fink AL, (2001) Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure. The Journal of biological chemistry 276: 44284-44296.
15. Paik SR, Lee JH, Kim DH, Chang CS, Kim J, (1997) Aluminum-induced structural alterations of the precursor of the non-A beta component of Alzheimer's disease amyloid. Archives of biochemistry and biophysics 344: 325-334.
16. Lewandowski NM, Ju S, Verbitsky M, Ross B, Geddie ML, et al. (2010) Polyamine pathway contributes to the pathogenesis of Parkinson disease. Proceedings of the National Academy of Sciences of the United States of America 107: 16970-16975.
17. McAllister C, Karymov MA, Kawano Y, Lushnikov AY, Mikheikin A, et al. (2005) Protein interactions and misfolding analyzed by AFM force spectroscopy. J Mol Biol 354: 1028-1042.
18. Yu J, Malkova S, Lyubchenko YL, (2008) alpha-Synuclein misfolding: single molecule AFM force spectroscopy study. Journal of molecular biology 384: 992-1001.
19. Lyubchenko YL, Kim BH, Krasnoslobodtsev AV, Yu J, (2010) Nanoimaging for protein misfolding diseases. Wiley interdisciplinary reviews Nanomedicine and nanobiotechnology 2: 526-543.
20. Kransnoslobodtsev AV, Shlyakhtenko LS, Ukraintsev E, Zaikova TO, Keana JF, et al. (2005) Nanomedicine and protein misfolding diseases. Nanomedicine 1: 300-305.
21. Yu J, Lyubchenko YL, (2009) Early stages for Parkinson's development: alpha-synuclein misfolding and aggregation. Journal of neuroimmune pharmacology: the official journal of the Society on NeuroImmune Pharmacology 4: 10-16.
22. Yu J, Warnke J, Lyubchenko YL, (2011) Nanoprobing of alpha-synuclein misfolding and aggregation with atomic force microscopy. Nanomedicine: nanotechnology, biology, and medicine 7: 146-152.
23. El-Agnaf OM, Bodles AM, Guthrie DJ, Harriott P, Irvine GB, (1998) The N-terminal region of non-A beta component of Alzheimer's disease amyloid is responsible for its tendency to assume beta-sheet and aggregate to form fibrils. European journal of biochemistry/FEBS 258: 157-163.
24. Kruger R, Kuhn W, Muller T, Woitalla D, Graeber M, et al. (1998) Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nature genetics 18: 106-108.
25. Kim BH, Palermo NY, Lovas S, Zaikova T, Keana JF, et al. (2011) Single-molecule atomic force microscopy force spectroscopy study of Abeta-40 interactions. Biochemistry 50: 5154-5162.
26. Yu J, Malkova S, Lyubchenko YL, (2008) alpha-Synuclein misfolding: single molecule AFM force spectroscopy study. J Mol Biol 384: 992-1001.
27. Giasson BI, Murray IV, Trojanowski JQ, Lee VM, (2001) A hydrophobic stretch of 12 amino acid residues in the middle of alpha-synuclein is essential for filament assembly. The Journal of biological chemistry 276: 2380-2386.
28. Bertoncini CW, Jung YS, Fernandez CO, Hoyer W, Griesinger C, et al. (2005) Release of long-range tertiary interactions potentiates aggregation of natively unstructured alpha-synuclein. Proceedings of the National Academy of Sciences of the United States of America 102: 1430-1435.
29. Lu Y, Prudent M, Fauvet B, Lashuel HA, Girault HH, (2011) Phosphorylation of α-Synuclein at Y125 and S129 Alters Its Metal Binding Properties: Implications for Understanding the Role of α-Synuclein in the Pathogenesis of Parkinson's Disease and Related Disorders. ACS Chemical Neuroscience 2: 667-675.
30. Antony T, Hoyer W, Cherny D, Heim G, Jovin TM, et al. (2003) Cellular polyamines promote the aggregation of alpha-synuclein. The Journal of biological chemistry 278: 3235-3240.
31. Fernandez CO, Hoyer W, Zweckstetter M, Jares-Erijman EA, Subramaniam V, et al. (2004) NMR of alpha-synuclein-polyamine complexes elucidates the mechanism and kinetics of induced aggregation. The EMBO journal 23: 2039-2046.
32. Hoyer W, Cherny D, Subramaniam V, Jovin TM, (2004) Impact of the acidic C-terminal region comprising amino acids 109-140 on alpha-synuclein aggregation in vitro. Biochemistry 43: 16233-16242.
33. Sandal M, Valle F, Tessari I, Mammi S, Bergantino E, et al. (2008) Conformational equilibria in monomeric alpha-synuclein at the single-molecule level. PLoS biology 6: e6.
34. Rospigliosi CC, McClendon S, Schmid AW, Ramlall TF, Barre P, et al. (2009) E46K Parkinson's-linked mutation enhances C-terminal-to-N-terminal contacts in alpha-synuclein. Journal of molecular biology 388: 1022-1032.
35. Wu KP, Kim S, Fela DA, Baum J, (2008) Characterization of conformational and dynamic properties of natively unfolded human and mouse alpha-synuclein ensembles by NMR: implication for aggregation. Journal of molecular biology 378: 1104-1115.
36. Heise H, Celej MS, Becker S, Riedel D, Pelah A, et al. (2008) Solid-state NMR reveals structural differences between fibrils of wild-type and disease-related A53T mutant alpha-synuclein. Journal of molecular biology 380: 444-450.
37. Li J, Uversky VN, Fink AL, (2001) Effect of familial Parkinson's disease point mutations A30P and A53T on the structural properties, aggregation, and fibrillation of human alpha-synuclein. Biochemistry 40: 11604-11613.
38. Conway KA, Lee SJ, Rochet JC, Ding TT, Williamson RE, et al. (2000) Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy. Proceedings of the National Academy of Sciences of the United States of America 97: 571-576.
39. Grabenauer M, Bernstein SL, Lee JC, Wyttenbach T, Dupuis NF, et al. (2008) Spermine binding to Parkinson's protein alpha-synuclein and its disease-related A30P and A53T mutants. The journal of physical chemistry B 112: 11147-11154.
40. Uversky VN, Lee HJ, Li J, Fink AL, Lee SJ, (2001) Stabilization of partially folded conformation during alpha-synuclein oligomerization in both purified and cytosolic preparations. The Journal of biological chemistry 276: 43495-43498.
41. Uversky VN, Li J, Fink AL, (2001) Evidence for a partially folded intermediate in alpha-synuclein fibril formation. The Journal of biological chemistry 276: 10737-10744.
42. Trexler AJ, Rhoades E, (2010) Single Molecule Characterization of α-Synuclein in Aggregation-Prone States. Biophysical Journal 99: 3048-3055.
43. Bertoncini CW, Fernandez CO, Griesinger C, Jovin TM, Zweckstetter M, (2005) Familial mutants of alpha-synuclein with increased neurotoxicity have a destabilized conformation. The Journal of biological chemistry 280: 30649-30652.
44. Brucale M, Sandal M, Di Maio S, Rampioni A, Tessari I, et al. (2009) Pathogenic mutations shift the equilibria of alpha-synuclein single molecules towards structured conformers. Chembiochem: a European journal of chemical biology 10: 176-183.
45. Losasso V, Pietropaolo A, Zannoni C, Gustincich S, Carloni P, (2011) Structural role of compensatory amino acid replacements in the alpha-synuclein protein. Biochemistry 50: 6994-7001.
46. Conway KA, Harper JD, Lansbury PT Jr, (2000) Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid. Biochemistry 39: 2552-2563.
47. Rochet JC, Conway KA, Lansbury PT Jr, (2000) Inhibition of fibrillization and accumulation of prefibrillar oligomers in mixtures of human and mouse alpha-synuclein. Biochemistry 39: 10619-10626.
48. Bulaj G, Kortemme T, Goldenberg DP, (1998) Ionization-reactivity relationships for cysteine thiols in polypeptides. Biochemistry 37: 8965-8972.
49. Oesterhelt F, Oesterhelt D, Pfeiffer M, Engel A, Gaub HE, et al. (2000) Unfolding Pathways of Individual Bacteriorhodopsins. Science 288: 143-146.